Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Industry Pricing Model Must Change, Former Merck CEO Vagelos Says

Executive Summary

The pharmaceutical industry needs to rethink its approach to pricing or face dire consequences, former Merck CEO Roy Vagelos told the Pharma, Biotech & Device Colloquium in Princeton, N.J. June 9

You may also be interested in...



Levin Calls Takeda/Shire Merger ‘Inspired,’ Says Entire Value Chain Must Address Pricing Issue

Having previously criticized the biopharma industry for squandering the benefits of US tax reform, the former Teva CEO called for more M&A deals that offer a clear strategic rationale, pointing to Takeda/Shire as an example.

Drug Development Needs “Extreme Makeover,” Researcher Topol Says

The pharmaceutical business needs an "extreme makeover," Cleveland Clinic cardiologist Eric Topol, MD, maintained during the 2004 Medical Innovation Summit in Cleveland

Drug Development Needs “Extreme Makeover,” Researcher Topol Says

The pharmaceutical business needs an "extreme makeover," Cleveland Clinic cardiologist Eric Topol, MD, maintained during the 2004 Medical Innovation Summit in Cleveland

Related Content

UsernamePublicRestriction

Register

PS044215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel